Art

J-GLOBAL ID：202102280780063176   Reference number：21A0293569

PD-1/PD-L1 expression profiles within intrahepatic cholangiocarcinoma predict clinical outcome

肝内胆管癌内のPD-1/PD-L1発現プロファイルは臨床転帰を予測する【JST・京大機械翻訳】

Author (11)： Tian Lingyu (Department of Liver Surgery and Transplantation, Liver Cancer Institute, Zhongshan Hospital and Key Laboratory of Carcinogenesis and Cancer Invasion, Fudan University, Shanghai, China) ,  Ma Jiaqiang (Department of Liver Surgery and Transplantation, Liver Cancer Institute, Zhongshan Hospital and Key Laboratory of Carcinogenesis and Cancer Invasion, Fudan University, Shanghai, China) ,  Ma Lijie (Department of General Surgery, Zhongshan Hospital (South), Shanghai Public Health Clinical Center, Fudan University, Shanghai, China) ,  Zheng Bohao (Department of General Surgery, Zhongshan Hospital, Fudan University, Shanghai, China) ,  Liu Longzi (Department of General Surgery, The First Affiliated Hospital of Nanchang University, Nanchang, China) ,  Song Danjun (Department of Liver Surgery and Transplantation, Liver Cancer Institute, Zhongshan Hospital and Key Laboratory of Carcinogenesis and Cancer Invasion, Fudan University, Shanghai, China) ,  Wang Yining (Department of Liver Surgery and Transplantation, Liver Cancer Institute, Zhongshan Hospital and Key Laboratory of Carcinogenesis and Cancer Invasion, Fudan University, Shanghai, China) ,  Zhang Zhao (Department of Hepatobiliary Surgery, The First Affiliated Hospital of Fujian Medical University, Fuzhou, China) ,  Gao Qiang (Department of Liver Surgery and Transplantation, Liver Cancer Institute, Zhongshan Hospital and Key Laboratory of Carcinogenesis and Cancer Invasion, Fudan University, Shanghai, China) ,  Song Kang (Department of Liver Surgery and Transplantation, Liver Cancer Institute, Zhongshan Hospital and Key Laboratory of Carcinogenesis and Cancer Invasion, Fudan University, Shanghai, China) ,  Wang Xiaoying (Department of Liver Surgery and Transplantation, Liver Cancer Institute, Zhongshan Hospital and Key Laboratory of Carcinogenesis and Cancer Invasion, Fudan University, Shanghai, China)
Material： World Journal of Surgical Oncology (Web)
Volume： 18  Issue： 1  Page： 1-11  Publication year： 2020 
JST Material Number： U7227A  ISSN： 1477-7819  Document type： Article
Article type： 原著論文  Country of issue： United Kingdom (GBR)  Language： ENGLISH (EN)

Abstract/Point： Immunotherapy targeting the pr...

Register(free) or Log In to access     To see more with JDream III (charged).   {{ this.onShowAbsJLink("http://jdream3.com/lp/jglobal/index.html?docNo=21A0293569&from=J-GLOBAL&jstjournalNo=U7227A") }}

Thesaurus term： tumor ,  Proteins ,  *T cell ,  Immunotherapy ,  macrophage ,  Prognosis ,  tumor invasion ,  risk factor ,  tumor immunity ,  immunohistochemistry ,  solid tumor ,  molecular target therapy ,  Ligands ,  programmed cell death
Semi thesaurus term： *肝内胆管癌 , 【Automatic Indexing@JST】

Author keywords (5)： Intrahepatic cholangiocarcinoma ,  Programmed cell death protein-1 ,  Programmed cell death protein ligand 1 ,  Immunotherapy ,  Tumor immune micro-environment

JST classification (1)： Tumor immunity  (ED03040A)

Reference (44)：

• J Am Coll Surg; Intrahepatic cholangiocarcinoma: management options and emerging therapies; RM Dodson; 217; 4; 2013; 736-750; 10.1016/j.jamcollsurg.2013.05.021; citation_id=CR1
• Lancet; Cholangiocarcinoma; N Razumilava, GJ Gores; 383; 9935; 2014; 2168-2179; 10.1016/S0140-6736(13)61903-0; citation_id=CR2
• Clin Gastroenterol Hepatol; Risk factors for intrahepatic and extrahepatic cholangiocarcinoma in the United States: a population-based case-control study; TM Welzel; 5; 10; 2007; 1221-1228; 10.1016/j.cgh.2007.05.020; citation_id=CR3
• World J Gastroenterol; Risk factors for intrahepatic cholangiocarcinoma: a case-control study in China; YM Zhou; 14; 4; 2008; 632-635; 10.3748/wjg.14.632; citation_id=CR4
• Nat Rev Gastroenterol Hepatol; Expert consensus document: Cholangiocarcinoma: current knowledge and future perspectives consensus statement from the European Network for the Study of Cholangiocarcinoma (ENS-CCA); JM Banales; 13; 5; 2016; 261-280; 10.1038/nrgastro.2016.51; citation_id=CR5

Terms in the title (6)： 肝内胆管癌 ,  PD-1 ,  PD-L1 ,  発現プロファイル ,  臨床転帰 ,  予測